Binan Lu

901 total citations
32 papers, 768 citations indexed

About

Binan Lu is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Binan Lu has authored 32 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Surgery. Recurrent topics in Binan Lu's work include Metabolism, Diabetes, and Cancer (4 papers), Berberine and alkaloids research (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Binan Lu is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Berberine and alkaloids research (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Binan Lu collaborates with scholars based in China and United States. Binan Lu's co-authors include Jinyong Peng, Lianhong Yin, Lina Xu, Yuetao Liu, Zongran Pang, Jinyong Peng, Youwei Xu, Mingming Hu, Kexin Liu and Xiaona Wang and has published in prestigious journals such as Food Chemistry, Chemosphere and Journal of Ethnopharmacology.

In The Last Decade

Binan Lu

31 papers receiving 754 citations

Peers

Binan Lu
Hai Wei China
Pan Li China
Binan Lu
Citations per year, relative to Binan Lu Binan Lu (= 1×) peers Xukun Deng

Countries citing papers authored by Binan Lu

Since Specialization
Citations

This map shows the geographic impact of Binan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binan Lu more than expected).

Fields of papers citing papers by Binan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binan Lu. The network helps show where Binan Lu may publish in the future.

Co-authorship network of co-authors of Binan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Binan Lu. A scholar is included among the top collaborators of Binan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binan Lu. Binan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xu, Wei Zhao, Ping Li, et al.. (2025). Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus. Frontiers in Pharmacology. 15. 1483792–1483792. 4 indexed citations
2.
Yang, Chen, Xin Pan, Wenqi Liu, et al.. (2023). Black mulberry extract inhibits hepatic adipogenesis through AMPK/mTOR signaling pathway in T2DM mice. Journal of Ethnopharmacology. 319(Pt 2). 117216–117216. 13 indexed citations
3.
Tian, Yu, et al.. (2023). The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK/PGC-1α/PPARα pathway. Diabetology & Metabolic Syndrome. 15(1). 145–145. 4 indexed citations
5.
Zhang, Yinjiang, et al.. (2022). Ferroptosis-related differentially expressed genes serve as new biomarkers in ischemic stroke and identification of therapeutic drugs. Frontiers in Nutrition. 9. 1010918–1010918. 4 indexed citations
6.
Zhou, Lu, et al.. (2022). Portulaca oleracea alleviates CCl4-induced acute liver injury by regulating hepatic S100A8 and S100A9. Chinese Herbal Medicines. 15(1). 110–116. 11 indexed citations
7.
Fan, Lu, et al.. (2022). Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway. Biomedicine & Pharmacotherapy. 148. 112697–112697. 11 indexed citations
8.
Lu, Binan, Ka-Li Zhu, Xiao-Ming Cui, et al.. (2022). Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors. Clinical Immunology. 244. 109103–109103. 3 indexed citations
9.
Zhang, Yuxin, Xing Wang, Binan Lu, et al.. (2021). Functional and binding studies of gallic acid showing platelet aggregation inhibitory effect as a thrombin inhibitor. Chinese Herbal Medicines. 14(2). 303–309. 23 indexed citations
10.
Guo, Ruixian, et al.. (2021). A systems toxicology approach to explore toxicological mechanisms of fluoroquinolones-induced testis injury. Ecotoxicology and Environmental Safety. 228. 113002–113002. 8 indexed citations
11.
Lu, Binan, et al.. (2021). Hypoglycemic effects of Tibetan medicine Huidouba in STZ-induced diabetic mice and db/db mice. Chinese Herbal Medicines. 13(2). 202–209. 16 indexed citations
12.
Zhang, Yinjiang, Hongyun Wei, Mingyan Fang, et al.. (2021). CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment. Frontiers in Cell and Developmental Biology. 9. 27 indexed citations
13.
Lu, Binan, et al.. (2020). Huidouba Improved Podocyte Injury by Down-Regulating Nox4 Expression in Rats With Diabetic Nephropathy. Frontiers in Pharmacology. 11. 587995–587995. 20 indexed citations
14.
Lu, Binan, et al.. (2013). The effect of chinese medicine pu-ren-dan on pancreatic angiogenesis in high fat diet/streptozotocin-induced diabetic rats. Indian Journal of Pharmacology. 45(6). 556–556. 4 indexed citations
15.
Zhang, Shuai, Binan Lu, Xu Han, et al.. (2012). Protection of the flavonoid fraction from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food and Chemical Toxicology. 55. 60–69. 96 indexed citations
16.
Yin, Lianhong, Yingnan Li, Binan Lu, Yujie Jia, & Jinyong Peng. (2010). Trends in Counter-Current Chromatography: Applications to Natural Products Purification. Separation and Purification Reviews. 39(1-2). 33–62. 16 indexed citations
18.
Lu, Binan, Mingming Hu, Kexin Liu, & Jinyong Peng. (2010). Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicology in Vitro. 24(6). 1482–1490. 51 indexed citations
19.
Lu, Binan, Yuetao Liu, Lianhong Yin, Xiaona Wang, & Jinyong Peng. (2009). Simple and reliable methods for the determination of sixteen marker components for quality control of Daochi pill by HPLC coupled with diode array detection. Phytochemical Analysis. 20(5). 385–394. 5 indexed citations
20.
Yin, Lianhong, Binan Lu, Yan Qi, et al.. (2009). Simultaneous determination of 11 active components in two well-known traditional Chinese medicines by HPLC coupled with diode array detection for quality control. Journal of Pharmaceutical and Biomedical Analysis. 49(4). 1101–1108. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026